University of British Columbia researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host. The discovery of the role played by the molecule CD74 could help immunologists investigate treatments that offer better immune responses against cancers, viruses and bacteria, and lead to more efficient vaccines. The findings are published in this week’s edition of Nature Immunology. “This could ultimately lead to a blueprint for improving the performance of a variety of vaccines, including... Read More
Congratulations to Kendra who has successfully defended her thesis titled Two novel transporters essential for the reassimilation of cholic acid metabolites excreted by Rhodococcus Jostii RHA1 in the Department of Microbiology and Immunology. Kendra has decided to continue her studies in Dr. Bill Mohn's Lab.
Congratulations to Erin who has successfully defended her Master's thesis and is currently attending Medical School in Calgary Alberta.
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases. More than 170 million people worldwide suffer from hepatitis C, the disease caused by chronic HCV infection. The disease affects the liver and is one of the leading causes of liver cancer and liver transplant around the world. HCV is spread by blood-to-blood contact and there is no vaccine to prevent it. Current treatments for the disease are only moderately... Read More
Congratulations to Stephanie who has accepted a position at Yale University working with Dr. Craig Roy as a post-doctoral research associate. Stephanie will be working on the obligate intracellular pathogen Coxiella burnetii and its interaction with host cells with a specific focus on the role of type IV effector proteins.